Department of Cardiology, Angiology and Intensive Care Medicine, University Heart Center Lübeck, Medical Clinic II, Lübeck, Germany.
Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
Am J Case Rep. 2021 Jun 4;22:e930381. doi: 10.12659/AJCR.930381.
BACKGROUND Cardiac perforation leading to cardiac tamponade is one of the possible complications of endocardial mapping during catheter-based ablation procedures. The early diagnosis of catheter-induced perforation is critical for effective management of these patients. We hereby present the diagnosis and management of left ventricular perforation during mapping of ventricular tachycardia in a patient with left ventricular aneurysm. CASE REPORT A 70-year-old man with a history of ischemic heart disease, arterial hypertension, type 2 diabetes mellitus, and obesity was referred to our institution for the ablative treatment of recurrent, sustained monomorphic ventricular tachycardia that was resistant to medication. One particularity was the presence of a left ventricular aneurysm secondary to a non-ST segment elevation myocardial infarction, which was unusual and could increase the risk of cardiac perforation. During left ventricular mapping, several points were acquired in an apparently unusual position and the pericardial location of the mapping catheter was confirmed fluoroscopically. After setting a pericardial pigtail catheter, we successfully finished the ablation procedure using a second ablation catheter. The perforating catheter was thereafter removed by open surgery, and no significant bleeding occurred. The patient did not experience tachycardia during the follow-up period of 29 months. CONCLUSIONS Left ventricular aneurysms might increase the cardiac perforation risk during endocardial mapping in ventricular tachycardia ablation procedures. In patients with this condition, a careful manipulation of the catheters could prevent such complications. The periodic fluoroscopic assessment of the catheter's position is essential for early recognition of the perforation.
心内导管标测消融术过程中,心内膜穿孔可导致心脏压塞,是一种可能发生的并发症。早期诊断导管所致穿孔对于此类患者的有效治疗至关重要。现报道一例左心室动脉瘤患者行室性心动过速标测时发生左心室穿孔的诊断和治疗经过。
一名 70 岁男性,有缺血性心脏病、动脉高血压、2 型糖尿病和肥胖病史,因药物难治性复发性持续性单形性室性心动过速而被转诊至我院行消融治疗。一个特别之处是存在左心室室壁瘤,继发于非 ST 段抬高型心肌梗死,这种情况较为少见,可能会增加心脏穿孔的风险。在左心室标测过程中,导管的几个部位处于明显异常的位置,通过透视确认了标测导管在心包内的位置。在心包内置入猪尾导管后,我们使用第二根消融导管成功完成了消融手术。随后通过开放手术取出穿孔导管,且无明显出血。在 29 个月的随访期间,患者未出现心动过速。
左心室室壁瘤可能会增加室性心动过速消融术中心内膜标测的心脏穿孔风险。对于此类患者,仔细操作导管可以预防此类并发症。定期透视评估导管位置对于早期识别穿孔至关重要。